Detection of VHL deletion by fluorescence in situ hybridization in extraneuraxial hemangioblastoma of soft tissue
Detection of VHL deletion by fluorescence in situ hybridization in extraneuraxial hemangioblastoma of soft tissue
复制标题
DOI:
10.1111/pin.12935
复制
发表时间:
2020-04
影响因子:
2.2
通讯作者:
K. Segawa;S. Sugita;Tomoyuki Aoyama;S. Minami;K. Nagashima;M. Tsuda;S. Tanaka;T. Hasegawa
中科院分区:
文献类型:
--
作者:
K. Segawa;S. Sugita;Tomoyuki Aoyama;S. Minami;K. Nagashima;M. Tsuda;S. Tanaka;T. Hasegawa
To the editor: Hemangioblastoma (HB) is a benign tumor that tends to occur in the central nervous system (CNS). Histologically, it is composed of proliferating stromal cells accompanied by mesh-like capillary vessels. Approximately 75% of HBs occur sporadically, with the remainder occurring in association with the autosomal dominantly inherited von Hippel-Lindau (VHL) disease. Multiple neoplasms can arise in various organs in VHL disease and may include HB of the CNS and spinal cord, retinal hemangioma, renal cell carcinoma, adrenal pheochromocytoma, and pancreatic neuroendocrine tumor. These neoplasms develop due to germline mutation of the VHL gene, which is a tumor suppressor gene mapped to chromosome 3p25-26. The VHL germline mutation and somatic VHL gene alterations have also been revealed in sporadic HBs of the CNS. It is known that some HBs occur in extraneuraxial sites including visceral organs, soft tissues, and bones, and extraneuraxial HBs develop sporadically in the setting of VHL disease. To date, however, few studies have analyzed the VHL gene in extraneuraxial HB [1]. Here, we report a case of sporadic extraneuraxial HB that arose from the soft tissue in which VHL gene deletion was detected by fluorescence in situ hybridization (FISH).